1.

[Article] McNicholas, Ruairi and Sweeney, Nicola and Fenton, Fiona and Keenan, Eamon (2025) Enhancing naloxone provision in patients with comorbid mental illness and opioid use disorder amidst the rise of nitazenes in Ireland. Irish Journal of Psychological Medicine, Early online. pp. 1-2. https://doi.org/10.1017/ipm.2025.10102

2.

[Report] National Records of Scotland. (2025) Drug-related deaths in Scotland, 2024. Edinburgh: National Records of Scotland.

3.

[Audio] Society for the Study of Addiction. (2025) Addiction audio. Season 3, 2025. London: Society for the Study of Addiction.

4.

[News] Public Health Scotland. Public health alert for action: Nitazene-type drugs in Scotland. (12 Aug 2025)

5.

[Article] Marland, Victoria and Nisbet, Lorna and Nic Daéid, Niamh (2025) Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. Harm Reduction Journal, 22. https://doi.org/10.1186/s12954-025-01287-9

6.

[Article] Mattsson, Molly and Flood, Michelle and MacKenna, Brian and Wallace, Emma and Boland, Fiona and Kirke, Ciara and Walsh, Mary E and Fahey, Tom and Moriarty, Frank (2025) Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022: a repeated cross-sectional study. British Journal of Clinical Pharmacology, Early online. https://doi.org/10.1002/bcp.70174

7.

[Article] Trullols, Maite and Ruiz de Porras, Vicenç (2025) Opioid use in cancer pain management: navigating the line between relief and addiction. International Journal of Molecular Sciences, 26, (15). https://doi.org/10.3390/ijms26157459

8.

[Article] Piatkowski, Timothy and Kill, Emma and Reeve, Steph (2025) ‘The gear could be cut with fentanyl which is starting to happen more in Australia’: exploring overdose survivors’ perspectives on toxic supply and safe consumption. Drugs: Education Prevention and Policy, 32, (1), pp. 42-50. https://doi.org/10.1080/09687637.2024.2392520

9.

[Article] Duddy, Claire (2025) What are synthetic drugs? House of Commons Library Insight,

10.

[Webpage] Center for Forensic Science Research and Education. (2025) CSFRE new psychoactive substances (NPS). Scope recommendations. URL: https://www.cfsre.org/nps-discovery/scope-recommen...

11.

[Report] Public Health Scotland. (2025) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2025. Edinburgh: Public Health Scotland.

12.

[News] [UNODC] UNODC: CND decision on international control of four nitazenes enters into force. (13 Jun 2025)

13.

[FactSheet] HRB National Drugs Library. (2025) Factsheet: New psychoactive substances (NPS) - the Irish situation. Dublin: HRB National Drugs Library.

14.

[Report] European Union Drugs Agency. (2025) Assessing the threat posed by the increased availability, use and harms of highly potent synthetic opioids in the Baltic region. Lisbon: EUDA.

15.

[Report] European Union Drugs Agency. (2025) Drug supply, production and precursors – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

16.

[Report] European Union Drugs Agency. (2025) Drug-induced deaths – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

17.

[Report] European Union Drugs Agency. (2025) Harm reduction – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

18.

[Report] European Union Drugs Agency. (2025) Heroin and other opioids – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

19.

[Report] European Union Drugs Agency. (2025) New psychoactive substances – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

20.

[Report] European Union Drugs Agency. (2025) Understanding Europe’s drug situation in 2024 – key developments (European Drug Report 2025). Lisbon: EUDA.

21.

[FactSheet] National Drug and Alcohol Research Centre. (2025) NDARC fact sheet: nitazenes. Sydney: National Drug and Alcohol Research Centre.

22.

[Article] Sandhu, Kanwarpreet Singh and Kumar, Siddarth and Garg, Keshav and Aggarwal, Kanishk and Tiwwary, Mayank and Perry, Griffin and Bansal, Vasu and Jain, Rohit (2025) The xylazine-fentanyl nexus: a public health emergency. SAGE Open Medicine, 13. https://doi.org/10.1177/20503121251348068

23.

[Article] Stangeland, Marcus and Dale, Ola and Skulberg, Arne Kristian (2025) Nitazenes: review of comparative pharmacology and antagonist action. Clinical Toxicology, 63, (6), pp. 393-406. https://doi.org/10.1080/15563650.2025.2504133

24.

[News] UNODC Early Warning Advisory on New Psychoactive Substances. [UNODC] May 2025 – Emerging analogues of brorphine. (30 May 2025)

25.

[Article] Zhang, Alice and Carrillo, Matthew and Liu, Ryan and Ballard, Sarah M and Reedy-Cooper, Alexis and Zgierska, Aleksandra E (2025) Vending machines for reducing harm associated with substance use and use disorders, and co-occurring conditions: a systematic review. Harm Reduction Journal, 22. https://doi.org/10.1186/s12954-025-01236-6

26.

[FactSheet] National Drug and Alcohol Research Centre. (2025) NDARC fact sheet: fentanyl. Sydney: National Drug and Alcohol Research Centre.

27.

[Article] Scher, Benjamin D and Southwell, Mat and Harris, Magdalena and Stevens, Alex and Chrisinger, Benjamin W and Humphreys, David K and Shorter, Gillian W (2025) Exploring the need for overdose prevention centers in England: a qualitative community-based participatory study on the perspectives of people who use drugs in public and semi-public environments. International Journal of Drug Policy, 140. https://doi.org/10.1016/j.drugpo.2025.104816

28.

[Article] Vickers-Smith, Rachel A and Gelberg, Kitty H and Childerhose, Janet E and Babineau, Denise C and Chandler, Redonna and David, James L and D'Costa, Lauren and Dzurec, Megan and Eggleston, Barry and Fallin-Bennett, Amanda and Fanucchi, Laura C and Fernandez, Soledad and Gilbert, Jace and Gilbert, Louisa and Hall, Megan E and Hiltz, Brooke E and Konstan, Michael W and Lancaster, Kathryn E and Linas, Beth and Marks, Katherine R and Michaels, Nichole and Miles, Jennifer and Montero, Fernando and Ramsey Harden, Haley J and Roeber, Carter and Russo, Mary R and Taylor, Rachel and Theis, Melissa A and Villani, Jennifer and Oga, Emmanuel and El-Bassel, Nabila and Walsh, Sharon L and Freisthler, Bridget (2025) Fentanyl test strip use and overdose risk reduction behaviors among people who use drugs. JAMA Network Open, 8, (5). https://doi.org/10.1001/jamanetworkopen.2025.10077

29.

[Report] Center for Forensic Science Research and Education. (2025) An update on the presence of BTMPS in the drug supply and the discovery of tetramethylfentanyl-related substances. United States: Center for Forensic Science Research and Education.

30.

[Webpage] HSE drugs.ie. (2025) Drug trend updates and warnings. URL: https://www.drugs.ie/drugs_info/drug_trend_updates...

31.

[Webpage] Public Health England. (2025) Preventing and reducing drug-related harm collection. URL: https://www.gov.uk/government/collections/preventi...

32.

[Webpage] Center for Forensic Science Research and Education. (2025) Novel psychoactive substances (NPS) trend reports. URL: https://www.cfsre.org/nps-discovery/trend-reports

33.

[Article] Gonzalez-Nieto, Pablo and Wallace, Bruce and Kielty, Collin and Gruntman, Kayla and Robinson, Derek and Gill, Chris and Arredondo Sanchez Lira, Jaime and Hore, Dennis (2025) Not just fentanyl: understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada. International Journal of Drug Policy, 138. https://doi.org/10.1016/j.drugpo.2025.104751

34.

[Article] Keemink, Jolie R and Stevens, Alex and Shirley-Beavan, Sam and Khadjesari, Zarnie and Shorter, Gillian W (2025) Four decades of overdose prevention centres: lessons for the future from a realist review. Harm Reduction Journal, 22. https://doi.org/10.1186/s12954-025-01178-z

35.

[Article] Bade, Richard and Nadarajan, Dhayaalini and Hall, Wayne and Brown, Jared A and Schumann, Jennifer (2025) Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: two years of data from 22 countries. Addiction, 120, (9), pp. 1739-1746. https://doi.org/10.1111/add.70027

36.

[Report] Health Research Board. Irish National Focal Point to the European Union Drugs Agency. (2025) Focal Point Ireland: national report for 2024 – drugs. Dublin: Health Research Board.

37.

[Article] Kral, Alex H and Humphrey, Jamie L and Schwab, Clyde and Lambdin, Barrot H and Ray, Bradley (2025) Law enforcement drug seizures and opioid-involved overdose mortality. JAMA Network Open, 8, (3). https://doi.org/10.1001/jamanetworkopen.2025.1158

38.

[Article] Gardner, Matthew and Bowden, Celeste and Manzoor, Shoaib and Cozier, Gyles E and Andrews, Rachael C and Craft, Sam and Skumlien, Martine and Sunderland, Peter and Tooth, Tom and Collins, Peter and Power, Alexander and Haines, Tom SF and Freeman, Tom P and Scott, Jennifer and Sutcliffe, Oliver B and Bowman, Richard W and Husbands, Stephen M and Pudney, Christopher R (2025) Field-portable device for detection of controlled and psychoactive substances from e-cigarettes. ACS Omega, 10, (8), pp. 7839-7847. https://doi.org/10.1021/acsomega.4c08614

39.

[Report] Health Research Board. Irish National Focal Point to the European Union Drugs Agency. (2025) Focal Point Ireland: national report for 2024 – drug markets and crime. Dublin: Health Research Board.

40.

[Report] TEDI members. Jones, G and Ventura, Mireia and Rigoni, Rafaela and Schiffer, Katrin (2025) European drug checking trends 2018 - 2024. Amsterdam: Correlation – European Harm Reduction Network.